Assessing Non-invasive Studies to Evaluate Resynchronization Pacing Effectiveness in the Young.

Area of Science:

• Cardiology
• Biomedical Engineering
• Pediatric Heart Disease

Background:

• Established non-invasive assessments for cardiac resynchronization therapy (CRT) response in young patients, particularly those with congenital heart disease (CHD), are lacking.
• Traditional echocardiography (ECHO) parameters like ejection fraction (EF) and QRS duration can be unreliable in this population due to anatomical variations, prior surgeries, and pacemakers.

Purpose of the Study:

• To correlate updated non-invasive assessments, including novel strain parameters, with clinical and invasive hemodynamic evaluations of CRT response in young patients.
• To establish more reliable non-invasive methods for assessing CRT efficacy in pediatric and young adult populations.

Main Methods:

• Sixteen young patients (mean age 18.5 years) with heart failure (NYHA II-III) underwent CRT.
• Assessments included clinical status (NYHA), invasive hemodynamics (dP/dt-max), ECG, and ECHO (including global longitudinal strain [GLS] and left atrial strain [LAS]) pre-CRT and at 1-month and 1-year post-CRT.

Main Results:

• All patients showed clinical improvement (NYHA II-III to I-II) and increased contractility (dP/dt) after 1 year.
• Standard ECHO parameters (EF, dimensions) showed minimal change, while GLS and LAS significantly improved post-CRT.
• QRS duration shortened only in patients with pre-existing pacemakers.

Conclusions:

• Cardiac resynchronization therapy is effective in younger patients with heart failure, including those with CHD.
• Novel echocardiographic strain parameters (GLS, LAS) offer superior, more accurate non-invasive assessment of CRT response compared to traditional metrics in this population.